Effects of a-lipoic acid on impaired gastric fundus innervation in diabetic rats

Thomas Michael Gibson, Mary Anne Cotter, Norman E Cameron

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Diabetes mellitus is a major cause of neuropathy, leading to adverse effects including autonomic gastrointestinal dysfunction. Oxidative stress contributes to the etiology of diabetic neuropathy. The aim was to examine whether treatment with the antioxidant, a-lipoic acid (LA), could prevent or correct diabetic functional defects in the gastric fundus non-adrenergic, non-cholinergic (NANC) nerves, which use nitric oxide as their major neurotransmitter. LA (100 mg/kg/d) was given in a prevention study for 8 weeks following streptozotocin-diabetes induction, and in an intervention study for 4 weeks after 4 weeks of untreated diabetes. Fundus strips were studied in vitro after precontraction with 5-hydroxytryptamine in the presence of guanethidine and atropine to isolate NANC relaxation to electrical field stimulation. After 4 and 8 weeks of diabetes, there were 26% and 48% deficits in maximum relaxation, respectively. Prevention LA treatment gave 83% protection; intervention LA prevented the deterioration between 4 and 8 weeks of diabetes and corrected the initial 4 week deficit by 56%. Diabetes also resulted in a failure to maintain relaxation for prolonged stimulation, which was prevented by LA. Thus, LA prevented and reversed the development of impaired gastric fundus NANC responses in diabetic rats, which has potential therapeutic implications for gastrointestinal autonomic neuropathy. (C) 2003 Elsevier Inc.

Original languageEnglish
Pages (from-to)160-168
Number of pages8
JournalFree Radical Biology and Medicine
Volume35
Issue number2
DOIs
Publication statusPublished - Jul 2003

Keywords

  • diabetes mellitus
  • gastric fundus
  • autonomic neuropathy
  • oxidative stress
  • NANC
  • nitric oxide
  • free radicals
  • NITRIC-OXIDE SYNTHASE
  • VASOACTIVE INTESTINAL POLYPEPTIDE
  • NERVE-CONDUCTION-VELOCITY
  • ENDONEURIAL BLOOD-FLOW
  • CORPUS CAVERNOSUM
  • OXIDATIVE STRESS
  • NEUROVASCULAR DYSFUNCTION
  • ANTIOXIDANT
  • RELAXATION
  • NEUROPATHY

Cite this

Effects of a-lipoic acid on impaired gastric fundus innervation in diabetic rats. / Gibson, Thomas Michael; Cotter, Mary Anne; Cameron, Norman E.

In: Free Radical Biology and Medicine, Vol. 35, No. 2, 07.2003, p. 160-168.

Research output: Contribution to journalArticle

Gibson, Thomas Michael ; Cotter, Mary Anne ; Cameron, Norman E. / Effects of a-lipoic acid on impaired gastric fundus innervation in diabetic rats. In: Free Radical Biology and Medicine. 2003 ; Vol. 35, No. 2. pp. 160-168.
@article{f68045ab58d64ea68ee608211ff68898,
title = "Effects of a-lipoic acid on impaired gastric fundus innervation in diabetic rats",
abstract = "Diabetes mellitus is a major cause of neuropathy, leading to adverse effects including autonomic gastrointestinal dysfunction. Oxidative stress contributes to the etiology of diabetic neuropathy. The aim was to examine whether treatment with the antioxidant, a-lipoic acid (LA), could prevent or correct diabetic functional defects in the gastric fundus non-adrenergic, non-cholinergic (NANC) nerves, which use nitric oxide as their major neurotransmitter. LA (100 mg/kg/d) was given in a prevention study for 8 weeks following streptozotocin-diabetes induction, and in an intervention study for 4 weeks after 4 weeks of untreated diabetes. Fundus strips were studied in vitro after precontraction with 5-hydroxytryptamine in the presence of guanethidine and atropine to isolate NANC relaxation to electrical field stimulation. After 4 and 8 weeks of diabetes, there were 26{\%} and 48{\%} deficits in maximum relaxation, respectively. Prevention LA treatment gave 83{\%} protection; intervention LA prevented the deterioration between 4 and 8 weeks of diabetes and corrected the initial 4 week deficit by 56{\%}. Diabetes also resulted in a failure to maintain relaxation for prolonged stimulation, which was prevented by LA. Thus, LA prevented and reversed the development of impaired gastric fundus NANC responses in diabetic rats, which has potential therapeutic implications for gastrointestinal autonomic neuropathy. (C) 2003 Elsevier Inc.",
keywords = "diabetes mellitus, gastric fundus, autonomic neuropathy, oxidative stress, NANC, nitric oxide, free radicals, NITRIC-OXIDE SYNTHASE, VASOACTIVE INTESTINAL POLYPEPTIDE, NERVE-CONDUCTION-VELOCITY, ENDONEURIAL BLOOD-FLOW, CORPUS CAVERNOSUM, OXIDATIVE STRESS, NEUROVASCULAR DYSFUNCTION, ANTIOXIDANT, RELAXATION, NEUROPATHY",
author = "Gibson, {Thomas Michael} and Cotter, {Mary Anne} and Cameron, {Norman E}",
year = "2003",
month = "7",
doi = "10.1016/S0891-5849(03)00242-9",
language = "English",
volume = "35",
pages = "160--168",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of a-lipoic acid on impaired gastric fundus innervation in diabetic rats

AU - Gibson, Thomas Michael

AU - Cotter, Mary Anne

AU - Cameron, Norman E

PY - 2003/7

Y1 - 2003/7

N2 - Diabetes mellitus is a major cause of neuropathy, leading to adverse effects including autonomic gastrointestinal dysfunction. Oxidative stress contributes to the etiology of diabetic neuropathy. The aim was to examine whether treatment with the antioxidant, a-lipoic acid (LA), could prevent or correct diabetic functional defects in the gastric fundus non-adrenergic, non-cholinergic (NANC) nerves, which use nitric oxide as their major neurotransmitter. LA (100 mg/kg/d) was given in a prevention study for 8 weeks following streptozotocin-diabetes induction, and in an intervention study for 4 weeks after 4 weeks of untreated diabetes. Fundus strips were studied in vitro after precontraction with 5-hydroxytryptamine in the presence of guanethidine and atropine to isolate NANC relaxation to electrical field stimulation. After 4 and 8 weeks of diabetes, there were 26% and 48% deficits in maximum relaxation, respectively. Prevention LA treatment gave 83% protection; intervention LA prevented the deterioration between 4 and 8 weeks of diabetes and corrected the initial 4 week deficit by 56%. Diabetes also resulted in a failure to maintain relaxation for prolonged stimulation, which was prevented by LA. Thus, LA prevented and reversed the development of impaired gastric fundus NANC responses in diabetic rats, which has potential therapeutic implications for gastrointestinal autonomic neuropathy. (C) 2003 Elsevier Inc.

AB - Diabetes mellitus is a major cause of neuropathy, leading to adverse effects including autonomic gastrointestinal dysfunction. Oxidative stress contributes to the etiology of diabetic neuropathy. The aim was to examine whether treatment with the antioxidant, a-lipoic acid (LA), could prevent or correct diabetic functional defects in the gastric fundus non-adrenergic, non-cholinergic (NANC) nerves, which use nitric oxide as their major neurotransmitter. LA (100 mg/kg/d) was given in a prevention study for 8 weeks following streptozotocin-diabetes induction, and in an intervention study for 4 weeks after 4 weeks of untreated diabetes. Fundus strips were studied in vitro after precontraction with 5-hydroxytryptamine in the presence of guanethidine and atropine to isolate NANC relaxation to electrical field stimulation. After 4 and 8 weeks of diabetes, there were 26% and 48% deficits in maximum relaxation, respectively. Prevention LA treatment gave 83% protection; intervention LA prevented the deterioration between 4 and 8 weeks of diabetes and corrected the initial 4 week deficit by 56%. Diabetes also resulted in a failure to maintain relaxation for prolonged stimulation, which was prevented by LA. Thus, LA prevented and reversed the development of impaired gastric fundus NANC responses in diabetic rats, which has potential therapeutic implications for gastrointestinal autonomic neuropathy. (C) 2003 Elsevier Inc.

KW - diabetes mellitus

KW - gastric fundus

KW - autonomic neuropathy

KW - oxidative stress

KW - NANC

KW - nitric oxide

KW - free radicals

KW - NITRIC-OXIDE SYNTHASE

KW - VASOACTIVE INTESTINAL POLYPEPTIDE

KW - NERVE-CONDUCTION-VELOCITY

KW - ENDONEURIAL BLOOD-FLOW

KW - CORPUS CAVERNOSUM

KW - OXIDATIVE STRESS

KW - NEUROVASCULAR DYSFUNCTION

KW - ANTIOXIDANT

KW - RELAXATION

KW - NEUROPATHY

U2 - 10.1016/S0891-5849(03)00242-9

DO - 10.1016/S0891-5849(03)00242-9

M3 - Article

VL - 35

SP - 160

EP - 168

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 2

ER -